Overview of IBI's rapid testing of analytes using a genetically engineered biosensor
investors main page
press room
events
partnering
clinical
environmental
careers

 

Management Team

IBI's management has extensive experience in the commercialization of innovative technologies in the pharmaceutical, research and diagnostic markets.

David A. Yost, Ph.D. President and Chief Executive Officer
When Dr. Yost joined IBI in 2008, his major role was to run the R&D organization and to develop IVD solutions for the Infectious Diseases market. In addition, to provide the company with direct and scientific leadership, to drive new product development and to provide continued support of current commercial products. He has almost 30 years of industrial experience in product development for the IVD and life science industries. Prior to joining IBI, Dr. Yost was a VP of R&D for the Biostar and Binax Divisions of Inverness Medical Innovations. Other key positions Dr. Yost has held were with Abbott Laboratories, Igen Inc., Celsis International and Tecan. Dr. Yost has successfully developed and managed the development of over 60 products during his career. He has published over 30 scientific papers and has been an inventor on over 10 U.S. patents. Dr. Yost holds a B.S. in Chemistry from Juniata College in Huntingdon, PA and a Ph.D. in Biochemistry from Virginia Polytechnic Institute and State University, Blacksburg, VA. He did a Post doctoral fellowship with the National Institutes of Health.

W. Rigg Mohler, Jr. CFO
Mr. Mohler has over 17 years of senior financial and operations experience. As a financial advisor to emerging organizations, Mr. Mohler oversees financial reporting and administration and assists with strategic planning, business models, acquisitions and Sarbanes-Oxley compliance. Clients in the biotechnology industry include Advancis Pharmaceuticals and Sequoia Pharmaceuticals. Mr. Mohler recently served as CFO of Whereoware LLC, an early stage software company. Previously, Mr. Mohler worked in corporate finance for Danaher Corporation and subsequently was appointed VP of Finance of a newly acquired manufacturing subsidiary. Mr. Mohler began his career with PricewaterhouseCoopers in its audit and real estate consulting practices. Mr. Mohler holds a Bachelor of Business Administration degree in Accounting from the College of William and Mary and is a certified public accountant.

 

The new symbol for unmatched speed and sensitivity in pathogen detection.

investors

Innovative Biosensors, Inc.
15601 Crabbs Branch Way
Rockville, MD 20855
301.738.0604
866.695.0417
301.738.0605
(fax)
info@innovativebiosensors.com

 

Legal Statement   Contact Us
© 2008-2011 Innovative Biosensors, Inc.